ergonovine has been researched along with Migraine Disorders in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (95.83) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buckingham, J; Glen, RC; Hill, AP; Hyde, RM; Martin, GR; Robertson, AD; Salmon, JA; Woollard, PM | 1 |
| GIRARD, M | 2 |
| BRUSSELMANS, P | 1 |
| POLLOCK, LA | 2 |
| DANNENBERG, T | 1 |
| GOTTHELF, EJ | 1 |
| FRIEDMAN, DA; FRIEDMAN, MD | 1 |
| ROTHLIN, E | 1 |
| BLUMENTHAL, LS; FUCHS, M | 3 |
| HERSCHBERG, AD | 1 |
| TABART, J | 1 |
| FRIEDMAN, AP; VON STORCH, TJ | 1 |
| BLUMENTAL, LS; FUCHS, M | 1 |
| Bonavita, JA; Epstein, DM; Gefter, WB; Miller, WT | 1 |
| Raskin, NH; Schwartz, RK | 1 |
| Prusiner, S; Raskin, NH | 1 |
| Swanson, JW; Vick, NA | 1 |
| Gallagher, RM | 1 |
| Barrie, MA; Fox, WR; Weatherall, M; Wilkinson, MI | 1 |
1 trial(s) available for ergonovine and Migraine Disorders
| Article | Year |
|---|---|
Analysis of symptoms of patients with headaches and their response to treatment with ergot derivatives.
Topics: Adolescent; Adult; Aged; Aspirin; Clinical Trials as Topic; Ergonovine; Ergotamine; Female; Headache; Humans; Male; Methysergide; Middle Aged; Migraine Disorders; Prochlorperazine; Time Factors; Weather | 1968 |
23 other study(ies) available for ergonovine and Migraine Disorders
| Article | Year |
|---|---|
Computer-aided design and synthesis of 5-substituted tryptamines and their pharmacology at the 5-HT1D receptor: discovery of compounds with potential anti-migraine properties.
Topics: Animals; Aorta; Computer-Aided Design; Drug Design; Haplorhini; In Vitro Techniques; Migraine Disorders; Models, Chemical; Rabbits; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1D; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Saphenous Vein; Serotonin Receptor Agonists; Structure-Activity Relationship; Tryptamines | 1995 |
[Effects of caffeinated ergotamine tartrate in migraine attacks; E. C. 110 or cafergon; first results].
Topics: Claviceps; Ergonovine; Ergot Alkaloids; Ergotamine; Migraine Disorders | 1950 |
The dihydroergotamine in the treatment of the migraine headache.
Topics: Claviceps; Ergonovine; Ergot Alkaloids; Migraine Disorders | 1948 |
Dihydroergotamine (D.H.E. 45), a new and effective drug in the treatment of migraine.
Topics: Claviceps; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Migraine Disorders | 1946 |
Comparison of dihydroergotamine, ergotamine and other agents in the treatment of migraine.
Topics: Claviceps; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Ergotamine; Migraine Disorders | 1946 |
D.H.E. 45 (dihydroergotamine) a new drug in the treatment of migraine.
Topics: Dihydroergotamine; Ergonovine; Ergot Alkaloids; Migraine Disorders | 1946 |
Dihydroergotamine in the treatment of migraine; preliminary clinical observations.
Topics: Claviceps; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Humans; Migraine Disorders | 1945 |
Historical development of the ergot therapy of migraine.
Topics: Cardiovascular Agents; Claviceps; Ergonovine; Ergot Alkaloids; Migraine Disorders | 1955 |
The excessive use of ergot.
Topics: Claviceps; Ergonovine; Ergot Alkaloids; Migraine Disorders | 1959 |
[Treatment of migraine by dihydroergotamine].
Topics: Dihydroergotamine; Ergonovine; Ergot Alkaloids; Humans; Migraine Disorders | 1950 |
[Treatment of migraine and persistent headache with ergotamine tartrate and novocaine aerosols].
Topics: Aerosols; Ergonovine; Ergot Alkaloids; Ergotamine; Headache; Migraine Disorders; Procaine | 1950 |
Recent advances in treatment of migraine.
Topics: Ergonovine; Ergot Alkaloids; Humans; Migraine Disorders | 1951 |
The use of ergot drugs for migraine.
Topics: Cardiovascular Agents; Claviceps; Ergonovine; Ergot Alkaloids; Migraine Disorders | 1952 |
Further experience with dihydroergotamine methanesulfonate in the treatment of migraine; with a note on the use of cafergone.
Topics: Claviceps; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Humans; Migraine Disorders | 1949 |
The use of ergot-caffeine suppositories in migraine.
Topics: Caffeine; Claviceps; Ergonovine; Ergot Alkaloids; Migraine Disorders; Suppositories | 1950 |
Use of ergot preparations in migraine.
Topics: Claviceps; Ergonovine; Ergot Alkaloids; Humans; Migraine Disorders | 1950 |
[Effects of caffeinated ergotamine tartrate in migraine attacks (E. C. 110 or cafergon); first results].
Topics: Claviceps; Ergonovine; Ergot Alkaloids; Ergotamine; Migraine Disorders | 1950 |
Pleural thickening caused by Sansert and Ergotrate in the treatment of migraine.
Topics: Adult; Asbestosis; Diagnosis, Differential; Ergonovine; Female; Humans; Male; Methysergide; Middle Aged; Migraine Disorders; Pleural Diseases; Radiography | 1980 |
Interval therapy of migraine: long-term results.
Topics: Adolescent; Adult; Aged; Amitriptyline; Cyproheptadine; Ergonovine; Ergotamine; Humans; Middle Aged; Migraine Disorders; Papaverine; Phenelzine; Propranolol; Time Factors | 1980 |
Carotidynia.
Topics: Adult; Aged; Carotid Artery Diseases; Dose-Response Relationship, Drug; Ergonovine; Female; Headache; Humans; Jaw Diseases; Methysergide; Middle Aged; Migraine Disorders; Nortriptyline; Pain; Propranolol | 1977 |
Basilar artery migraine 12 patients, with an attack recorded electroencephalographically.
Topics: Adolescent; Adult; Basilar Artery; Cerebral Arterial Diseases; Child; Child, Preschool; Electroencephalography; Epilepsy; Ergonovine; Female; Humans; Male; Middle Aged; Migraine Disorders | 1978 |
Menstrual migraine and intermittent ergonovine therapy.
Topics: Adult; Ergonovine; Female; Humans; Menstruation Disturbances; Migraine Disorders | 1989 |
Prophylaxis of recurrent headache.
Topics: Ergonovine; Ergotamine; Headache; Humans; Methysergide; Migraine Disorders | 1969 |